Nisa Investment Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8K | Sell |
1,205
-122
| -9% | -$1.71K | ﹤0.01% | 2025 |
|
|
2025
Q1 | $17.9K | Buy |
1,327
+86
| +7% | +$1.16K | ﹤0.01% | 1927 |
|
|
2024
Q4 | $23.8K | Buy |
1,241
+193
| +18% | +$3.7K | ﹤0.01% | 1885 |
|
|
2024
Q3 | $23.8K | Sell |
1,048
-84
| -7% | -$1.91K | ﹤0.01% | 1858 |
|
|
2024
Q2 | $14.7K | Buy |
1,132
+1,057
| +1,409% | +$13.8K | ﹤0.01% | 2043 |
|
|
2024
Q1 | $1.31K | Buy |
75
+45
| +150% | +$788 | ﹤0.01% | 2315 |
|
|
2023
Q4 | $653 | Buy |
30
+10
| +50% | +$218 | ﹤0.01% | 2355 |
|
|
2023
Q3 | $307 | Sell |
20
-865
| -98% | -$13.3K | ﹤0.01% | 2609 |
|
|
2023
Q2 | $21.1K | Buy |
885
+240
| +37% | +$5.71K | ﹤0.01% | 2081 |
|
|
2023
Q1 | $16K | Buy |
645
+620
| +2,480% | +$15.4K | ﹤0.01% | 2073 |
|
|
2022
Q4 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 2527 |
|